Date | Time | Source | Headline | Symbol | Company |
03/03/2008 | 4:36PM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
02/27/2008 | 4:20PM | PR Newswire (US) | Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement | NYSE:FRX | Forest Road Acquisition Corp |
02/27/2008 | 4:17PM | PR Newswire (US) | Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement | NYSE:FRX | Forest Road Acquisition Corp |
02/27/2008 | 10:23AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
02/27/2008 | 10:13AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/21/2008 | 5:48PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
02/21/2008 | 8:00AM | Marketwired | Forest and Cypress Announce FDA Acceptance for Review of New Drug Application for Milnacipran for the Treatment of Fibromyalgia | NYSE:FRX | Forest Road Acquisition Corp |
02/14/2008 | 1:33PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
02/14/2008 | 12:09PM | Edgar (US Regulatory) | Forest Laboratories Inc - Schedule 13G (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/14/2008 | 10:55AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/12/2008 | 5:15PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
02/12/2008 | 12:18PM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/11/2008 | 3:28PM | Edgar (US Regulatory) | Forest Laboratories Inc - Quarterly Report (10-Q) | NYSE:FRX | Forest Road Acquisition Corp |
02/11/2008 | 11:29AM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/08/2008 | 3:35PM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/08/2008 | 3:34PM | Edgar (US Regulatory) | Forest Laboratories Inc - Amended Statement of Ownership (SC 13G/A) | NYSE:FRX | Forest Road Acquisition Corp |
02/05/2008 | 4:46PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Ownership (SC 13G) | NYSE:FRX | Forest Road Acquisition Corp |
02/05/2008 | 8:02AM | PR Newswire (US) | Forest Laboratories, Inc. Announces Positive Results of Memantine Study of Once-Daily Formulation | NYSE:FRX | Forest Road Acquisition Corp |
01/25/2008 | 12:39PM | PR Newswire (US) | Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Additional Lawsuit Against Several Companies for Patent Infringem | NYSE:FRX | Forest Road Acquisition Corp |
01/22/2008 | 7:30AM | PR Newswire (US) | Novexel and Forest Laboratories Announce License Agreement for NXL 104, a Novel Broad-Spectrum Beta Lactamase Inhibitor | NYSE:FRX | Forest Road Acquisition Corp |
01/18/2008 | 10:42AM | Edgar (US Regulatory) | Forest Laboratories Inc - Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
01/17/2008 | 9:51AM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
01/15/2008 | 9:31AM | PR Newswire (US) | Seven Summits Research Releases Alerts on MSFT, RIMM, WLP, FRX, and BBT | NYSE:FRX | Forest Road Acquisition Corp |
01/15/2008 | 7:50AM | PR Newswire (US) | Forest Laboratories, Inc. Reports Q3'08 Diluted Earnings Per Share of $0.96. Raises FY2008 EPS Guidance Range to $3.35-$3.45 Exc | NYSE:FRX | Forest Road Acquisition Corp |
01/10/2008 | 5:05PM | PR Newswire (US) | Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement | NYSE:FRX | Forest Road Acquisition Corp |
01/08/2008 | 4:07PM | Edgar (US Regulatory) | Forest Laboratories Inc - Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
01/04/2008 | 8:35AM | PR Newswire (US) | Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings | NYSE:FRX | Forest Road Acquisition Corp |
12/31/2007 | 7:05AM | PR Newswire (US) | Forest and Cypress Announce Submission of New Drug Application for Milnacipran for the Treatment of Fibromyalgia Syndrome | NYSE:FRX | Forest Road Acquisition Corp |
12/18/2007 | 6:30AM | PR Newswire (US) | Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension | NYSE:FRX | Forest Road Acquisition Corp |
12/13/2007 | 4:20PM | PR Newswire (US) | Forest Laboratories Receives Notification of ANDA Filings for Generic Equivalents of Namenda(R) | NYSE:FRX | Forest Road Acquisition Corp |